Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires Live2025-03-25

Health care stocks climbed late Monday afternoon with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) rising 0.8%.

The iShares Biotechnology ETF (IBB) climbed 1.3%.

In corporate news, Unity Biotechnology (UBX) shares fell 28%. The company's UBX1325, the diabetic macular edema treatment for patients with poor vision, didn't achieve statistical non-inferiority at the primary analysis endpoint in a phase 2b trial.

TransCode Therapeutics (RNAZ) shares dropped 38%. The company agreed to sell shares to raise $10 million.

23andMe (ME) filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive officer, less than a month after she attempted to buy the genetic testing firm. 23andMe shares tumbled 59%.

Novo Nordisk (NVO) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. Novo shares shed 2%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2522792702?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-25 03:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522792702","market":"nz","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Rise Late Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks climbed late Monday afternoon with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) rising 0.8%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) climbed 1.3%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/UBX\">Unity Biotechnology</a> (UBX) shares fell 28%. The company's UBX1325, the diabetic macular edema treatment for patients with poor vision, didn't achieve statistical non-inferiority at the primary analysis endpoint in a phase 2b trial.</p><p>TransCode <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (RNAZ) shares dropped 38%. The company agreed to sell shares to raise $10 million.</p><p>23andMe (ME) filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive officer, less than a month after she attempted to buy the genetic testing firm. 23andMe shares tumbled 59%.</p><p>Novo Nordisk (NVO) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. Novo shares shed 2%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Rise Late Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Rise Late Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-25 03:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks climbed late Monday afternoon with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) rising 0.8%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) climbed 1.3%.</p><p>In corporate news, <a href=\"https://laohu8.com/S/UBX\">Unity Biotechnology</a> (UBX) shares fell 28%. The company's UBX1325, the diabetic macular edema treatment for patients with poor vision, didn't achieve statistical non-inferiority at the primary analysis endpoint in a phase 2b trial.</p><p>TransCode <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (RNAZ) shares dropped 38%. The company agreed to sell shares to raise $10 million.</p><p>23andMe (ME) filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive officer, less than a month after she attempted to buy the genetic testing firm. 23andMe shares tumbled 59%.</p><p>Novo Nordisk (NVO) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. Novo shares shed 2%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2522792702","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522792702","pubTimestamp":1742846194,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks climbed late Monday afternoon with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund  rising 0.8%.The iShares Biotechnology ETF  climbed 1.3%.In corporate news, Unity Biotechnology  shares fell 28%. The company's UBX1325, the diabetic macular edema treatment for patients with poor vision, didn't achieve statistical non-inferiority at the primary analysis endpoint in a phase 2b trial.TransCode Therapeutics  shares dropped 38%. The company agreed to sell shares to raise $10 million.23andMe  filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive officer, less than a month after she attempted to buy the genetic testing firm. 23andMe shares tumbled 59%.Novo Nordisk  secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. Novo shares shed 2%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","BK7104":"黄金","XLV":"健康照护类股ETF-SPDR","NVO.AU":"NOVO RESOURCES CORP-CDI","BK4588":"碎股","IBB":"生物科技指数ETF-iShares Nasdaq","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","MEHCQ":"CHROME HLDG CO","BK4007":"制药","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","RNAZ":"TransCode Therapeutics  Inc.","BK4196":"保健护理服务","BK4539":"次新股","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4581":"高盛持仓","BK4599":"减肥药","BK4532":"文艺复兴科技持仓","UBX":"Unity Biotechnology","BK4121":"生命科学工具和服务","BK4585":"ETF&股票定投概念"},"translate_title":"行业更新：医疗保健股午后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IBB":1,"UBX":0.9,"RNAZ":0.9,"NVO.AU":1,"XLV":1,"ME":0.9,"MEHCQ":0.9},"content_text":"Health care stocks climbed late Monday afternoon with the NYSE Health Care Index up 0.5% and the Health Care Select Sector SPDR Fund (XLV) rising 0.8%.The iShares Biotechnology ETF (IBB) climbed 1.3%.In corporate news, Unity Biotechnology (UBX) shares fell 28%. The company's UBX1325, the diabetic macular edema treatment for patients with poor vision, didn't achieve statistical non-inferiority at the primary analysis endpoint in a phase 2b trial.TransCode Therapeutics (RNAZ) shares dropped 38%. The company agreed to sell shares to raise $10 million.23andMe (ME) filed for Chapter 11 bankruptcy protection to help facilitate a potential sale, while Anne Wojcicki resigned as chief executive officer, less than a month after she attempted to buy the genetic testing firm. 23andMe shares tumbled 59%.Novo Nordisk (NVO) secured exclusive global rights to United Laboratories International's therapeutic candidate for obesity and type 2 diabetes in a licensing deal worth up to $2 billion. Novo shares shed 2%.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2522792702","isCrawlerRequest":true}